December 23, 2024

Common Over-the-Counter Medication May Provide Relief for People With Long COVID-19 Symptoms

The effects of COVID-19 on people vary from mild symptoms to several weeks of health problem to ailments consisting of brain fog, joint discomfort, exercise intolerance, and fatigue that last for months after the preliminary infection. The clinical term for these lingering long COVID-19 results is post-acute sequelae of SARS-CoV-2, for which there is no basic treatment.
A number of choices are being attempted, with antihistamines being one of them. The possibility that an easy-to-access, over-the-counter medication could alleviate some of the PASC signs need to use hope to the estimated 54 million people worldwide who have been in distress for months or even years.”
” Patients struggling with long COVID are desperate to get back on their feet and acquire relief from signs that affect their ability to function. The case report explains the experiences of 2 PASC patients and reveals the potential advantages of using antihistamines, under medical supervision, to treat their signs,” states Melissa Pinto, UCI associate teacher of nursing. Credit: Sue & & Bill Gross School of Nursing/ UCI
The case report, recently released in The Journal for Nurse Practitioners, describes 2 healthy, active middle-aged ladies with PASC who found, by opportunity, that antihistamines resulted in significantly boosted daily function, now sustained for almost a year. Both took over-the-counter antihistamines to treat other conditions– the first one had actually activated her dairy allergic reaction by eating cheese, and the other had run out of the allergic reaction medication she normally took– and experienced enhanced cognition and much less fatigue the next morning. The first females long COVID-19 symptoms also consisted of exercise intolerance, chest discomfort, headaches, a rash, and bruising, while the 2nd handled abdominal and joint pain, as well as the rashes and lesions called “COVID toes.”
In the very first case, the woman didnt take another antihistamine for 72 hours; when her symptoms reappeared, she took the medication and again found relief. With assistance from her main doctor, who recommended her an antihistamine, she began an everyday dosage that has actually significantly decreased her other long COVID-19 signs. She reported that she has restored 90 percent of her pre-COVID-19 everyday function.
In the second case, the woman took a different non-prescription antihistamine as a replacement for what she had taken for years to manage her seasonal allergies. After keeping in mind that her long COVID-19 fatigue and cognition had actually improved, she continued to take it daily in addition to other allergic reaction medication. Her course of treatment, which now includes both over the counter medications, has also considerably reduced her additional long COVID-19 signs. She reported that she has actually gained back 95 percent of her pre-illness functioning.
Previous research studies, including those in the Journal of Investigative Medicine and Pulmonary Pharmacology & & Therapeutics, have actually likewise shown the prospective benefit of antihistamines as treatment for PASC.
” Most patients tell us that companies have not suggested anything that has assisted. I urge them to do so under medical supervision if clients desire to try OTC antihistamines. And since suppliers may not understand about brand-new potential treatments, I would motivate clients to be active in their care and consider taking research study and case reports like ours to consultations with companies so they can assist develop a routine that will work,” Pinto stated. “The next actions for this research into antihistamine treatment are to conduct broad-based trials in order to evaluate effectiveness and to establish dosage schedules for medical practice standards.”
Recommendation: “Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection” by Melissa D. Pinto, Natalie Lambert, Charles A. Downs, Heather Abrahim, Thomas D. Hughes, Amir M. Rahmani, Candace W. Burton and Rana Chakraborty, 7 February 2022, The Journal for Nurse Practitioners.DOI: 10.1016/ j.nurpra.2021.12.016.
Additional co-authors on the report are Amir Rahmani and Candace Burton, UCI associate teachers of nursing; Thomas Hughes and Heather Abrahim, UCI nursing science graduate students; Natalie Lambert, associate research study professor of biostatistics & & health information science at the Indiana University School of Medicine; Dr. Rana Chakraborty, pediatric contagious illness specialist at the Mayo Clinic; and Charles Downs, associate professor at the University of Miami School of Nursing & & Health Studies.

Extensively available, over the counter antihistamines have the prospective to bring back daily function.
Antihistamines may provide relief for the countless individuals experiencing the painful, incapacitating symptoms of long COVID-19 that impair daily functioning. Thats the conclusion of a case report on the experiences of two such clients co-authored by nursing scholars at the University of California, Irvine.

The case report explains the experiences of 2 PASC clients and reveals the possible advantages of utilizing antihistamines, under medical supervision, to treat their symptoms,” says Melissa Pinto, UCI associate professor of nursing. The case report, just recently released in The Journal for Nurse Practitioners, explains two healthy, active middle-aged females with PASC who found, by possibility, that antihistamines led to greatly improved everyday function, now sustained for nearly a year. In the first case, the lady didnt take another antihistamine for 72 hours; when her symptoms reappeared, she took the medication and again found relief. With assistance from her main health care service provider, who prescribed her an antihistamine, she began a day-to-day dosage that has considerably reduced her other long COVID-19 signs. In the 2nd case, the lady took a different over-the-counter antihistamine as an alternative for what she had taken for years to handle her seasonal allergies.